Session IV - Advances in Fistulizing Crohn’s Disease: Emerging Therapies and Patient-Centric Management Strategies
Saturday, July 22, 2023
8:15 AM – 9:00 AM .
This session is supported by an independent educational grant from Takeda Pharmaceuticals U.S.A.
Learning Objectives:
Describe the burden, unmet needs, and management challenges associated with fistulizing CD
Evaluate the most recent clinical data associated with newer and emerging therapies for fistulizing CD
Implement coordinated, patient-centered management strategies based on the most current evidence and consensus-based guidelines for the management of fistulizing CD